费城染色体阳性白血病-话题@MedSci

#费城染色体阳性白血病#

3篇内容 | 1048人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2262243, encodeId=a3c922622432d, content=<a href='/topic/show?id=ccdf93951a7' target=_blank style='color:#2F92EE;'>#达沙替尼#</a> <a href='/topic/show?id=da8c92503e7' target=_blank style='color:#2F92EE;'>#费城染色体阳性白血病#</a> <a href='/topic/show?id=4e2640e283' target=_blank style='color:#2F92EE;'>#CAR-T细胞#</a>, objectTitle=JAMA Oncol | 达沙替尼与CAR T细胞联合治疗新诊断费城染色体阳性急性淋巴细胞白血病的疗效与安全性, objectType=article, longId=873499, objectId=f83b8e349966, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721281386020_92910.jpg, objectUrl=/article/show_article.do?id=f83b8e349966, replyNumber=0, likeNumber=23, createdTime=2025-04-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f83b8e349966, moduleTitle=JAMA Oncol | 达沙替尼与CAR T细胞联合治疗新诊断费城染色体阳性急性淋巴细胞白血病的疗效与安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f83b8e349966)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1628891, encodeId=f04116288916c, content=<a href='/topic/show?id=da8c92503e7' target=_blank style='color:#2F92EE;'>#费城染色体阳性白血病#</a>, objectTitle=NEJM：Asciminib二线治疗费城染色体阳性白血病, objectType=article, longId=184673, objectId=05d51846e3ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05d51846e3ec, replyNumber=0, likeNumber=80, createdTime=2019-12-14, rootId=0, userName=cy0331, userId=03f421226458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05d51846e3ec, moduleTitle=NEJM：Asciminib二线治疗费城染色体阳性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05d51846e3ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1628890, encodeId=f8371628890bf, content=<a href='/topic/show?id=da8c92503e7' target=_blank style='color:#2F92EE;'>#费城染色体阳性白血病#</a>, objectTitle=Blood：帕纳替尼（Ponatinib）用于慢性髓系白血病和费城染色体阳性白血病患者，可获得持久缓解, objectType=article, longId=133362, objectId=b4771333624d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4771333624d, replyNumber=0, likeNumber=72, createdTime=2018-03-26, rootId=0, userName=cy0331, userId=03f421226458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4771333624d, moduleTitle=Blood：帕纳替尼（Ponatinib）用于慢性髓系白血病和费城染色体阳性白血病患者，可获得持久缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4771333624d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1628889, encodeId=07ec1628889dd, content=<a href='/topic/show?id=da8c92503e7' target=_blank style='color:#2F92EE;'>#费城染色体阳性白血病#</a>, objectTitle=NEJM:Ponatinib可有效治疗费城染色体阳性白血病, objectType=article, longId=26672, objectId=a603266e293, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a603266e293, replyNumber=0, likeNumber=88, createdTime=2013-11-20, rootId=0, userName=cy0331, userId=03f421226458, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a603266e293, moduleTitle=NEJM:Ponatinib可有效治疗费城染色体阳性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a603266e293)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

费城染色体阳性白血病

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#达沙替尼# #费城染色体阳性白血病# #CAR-T细胞#

JAMA Oncol | 达沙替尼与CAR T细胞联合治疗新诊断费城染色体阳性急性淋巴细胞白血病的疗效与安全性

2025-04-25发表于陕西省

cy0331 (审核中...)

前往app查看评论内容

#费城染色体阳性白血病#

NEJM：Asciminib二线治疗费城染色体阳性白血病

2019-12-14

cy0331 (审核中...)

前往app查看评论内容

#费城染色体阳性白血病#

Blood：帕纳替尼（Ponatinib）用于慢性髓系白血病和费城染色体阳性白血病患者，可获得持久缓解

2018-03-26

cy0331 (审核中...)

前往app查看评论内容

#费城染色体阳性白血病#

NEJM:Ponatinib可有效治疗费城染色体阳性白血病

2013-11-20

科室
- - 订阅+
  - 更多科室
工具
服务